BioCentury
ARTICLE | Company News

Hisamitsu, Shionogi sales and marketing update

January 27, 2014 8:00 AM UTC

Hisamitsu's Noven Pharmaceuticals Inc. subsidiary and Shionogi will exclusively co-promote Brisdelle paroxetine in the U.S. The low-dose selective serotonin reuptake inhibitor (SSRI) is approved to ...